EU/3/10/811 - orphan designation for treatment of post-polycythaemia vera myelofibrosis
N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate (fedratinib)
Orphan
Human